TEL/AML ALL FISH Test: Comprehensive Genetic Screening for Acute Lymphoblastic Leukemia
Understanding the TEL/AML ALL FISH Test
The TEL/AML ALL FISH Test represents a cutting-edge diagnostic approach in the field of hematological oncology, specifically designed to detect chromosomal abnormalities associated with acute lymphoblastic leukemia (ALL). This sophisticated genetic screening utilizes fluorescence in situ hybridization (FISH) technology to identify specific genetic rearrangements that play pivotal roles in leukemia development and progression.
Acute lymphoblastic leukemia is the most common childhood cancer, though it can affect individuals of all ages. The TEL/AML1 fusion gene, resulting from a translocation between chromosomes 12 and 21, represents one of the most frequent genetic abnormalities in pediatric ALL cases. Detecting this specific genetic alteration provides crucial information for accurate diagnosis, prognosis assessment, and treatment planning.
What the Test Measures and Detects
The TEL/AML ALL FISH Test specifically targets and identifies:
- TEL-AML1 fusion gene resulting from t(12;21) translocation
- Presence of abnormal genetic rearrangements in bone marrow or blood cells
- Chromosomal abnormalities associated with ALL development
- Genetic markers that influence treatment response and disease prognosis
- Minimal residual disease monitoring capabilities
This advanced genetic analysis provides molecular-level insights that traditional cytogenetic methods might miss, offering enhanced sensitivity and specificity in detecting leukemia-associated genetic changes.
Who Should Consider This Test
The TEL/AML ALL FISH Test is recommended for individuals experiencing:
- Unexplained fatigue, weakness, or persistent tiredness
- Frequent infections or prolonged recovery from illnesses
- Unexplained bruising, bleeding, or petechiae (small red spots)
- Bone pain or joint discomfort without clear cause
- Enlarged lymph nodes, spleen, or liver
- Unexplained weight loss or loss of appetite
- Fever without apparent infection
- Pale skin or signs of anemia
- Abnormal blood cell counts in routine laboratory tests
Additionally, this test is crucial for patients already diagnosed with ALL to determine specific genetic subtypes and guide targeted treatment approaches.
Benefits of Taking the TEL/AML ALL FISH Test
Choosing the TEL/AML ALL FISH Test provides numerous advantages:
- Precise Diagnosis: Accurate identification of specific genetic abnormalities associated with ALL
- Personalized Treatment Planning: Results guide targeted therapy selection based on genetic profile
- Prognostic Information: Helps predict disease course and treatment response
- Early Detection: Identifies genetic changes before clinical symptoms become severe
- Treatment Monitoring: Tracks response to therapy and detects minimal residual disease
- Family Risk Assessment: Provides information about potential genetic predispositions
- Comprehensive Analysis: Offers detailed genetic insights beyond standard testing methods
Understanding Your Test Results
Your TEL/AML ALL FISH Test results will be carefully interpreted by our expert genetic counselors and hematologists:
Positive Results
A positive result indicates the presence of the TEL-AML1 fusion gene or other significant genetic abnormalities associated with ALL. This finding typically confirms the diagnosis of acute lymphoblastic leukemia and provides essential information for treatment planning. Patients with TEL-AML1 positive ALL often have favorable prognosis with appropriate therapy.
Negative Results
A negative result suggests the absence of the specific genetic abnormalities tested. However, this does not completely rule out ALL, as other genetic alterations might be present. Further testing may be recommended based on clinical presentation and other laboratory findings.
Inconclusive Results
In rare cases, results may be inconclusive due to technical factors or sample quality. In such situations, repeat testing or alternative diagnostic methods may be recommended.
Test Pricing and Details
| Test Component | Details |
|---|---|
| Test Name | TEL/AML ALL FISH Test |
| Regular Price | $176 USD |
| Discount Price | $132 USD |
| Turnaround Time | 3-4 Days |
| Sample Type | Bone Marrow / Peripheral Blood |
| Test Components | Sodium Heparin Vacutainer (2ml) |
| Pre-test Instructions | Doctor’s prescription required (not applicable for surgery, pregnancy, or international travel cases) |
Nationwide Availability
We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas. Our state-of-the-art facilities in New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose ensure accessible genetic testing services for patients nationwide.
Take Control of Your Health Today
Early detection and precise genetic characterization are crucial in managing acute lymphoblastic leukemia effectively. The TEL/AML ALL FISH Test provides the comprehensive genetic information needed for accurate diagnosis and personalized treatment planning.
Ready to schedule your TEL/AML ALL FISH Test? Contact our dedicated healthcare team today at +1(267) 388-9828 to book your appointment or discuss your testing needs. Our genetic counselors are available to answer your questions and guide you through the testing process.
Don’t wait to get the answers you need for better health outcomes. Book your comprehensive genetic screening today and take the first step toward personalized leukemia management and treatment planning.
